ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Eyenovia Inc

Eyenovia Inc (EYEN)

0.3401
-0.0674
(-16.54%)
Closed November 14 4:00PM
0.3401
0.00
( 0.00% )
Pre Market: 6:57AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.3401
Bid
0.3401
Ask
0.386
Volume
27
0.00 Day's Range 0.00
0.33 52 Week Range 2.57
Market Cap
Previous Close
0.3401
Open
-
Last Trade
5
@
0.3557
Last Trade Time
06:46:50
Financial Volume
-
VWAP
-
Average Volume (3m)
1,154,431
Shares Outstanding
76,910,000
Dividend Yield
-
PE Ratio
-0.96
Earnings Per Share (EPS)
-0.35
Revenue
4k
Net Profit
-27.26M

About Eyenovia Inc

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precis... Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Eyenovia Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EYEN. The last closing price for Eyenovia was $0.34. Over the last year, Eyenovia shares have traded in a share price range of $ 0.33 to $ 2.57.

Eyenovia currently has 76,910,000 shares outstanding. The market capitalization of Eyenovia is $26.16 million. Eyenovia has a price to earnings ratio (PE ratio) of -0.96.

EYEN Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1499-30.59183673470.490.51320.3321117670.41136517CS
4-0.1699-33.31372549020.510.59160.3311587830.48002133CS
12-0.227-40.02821371890.56710.650.3311544310.50768677CS
26-0.5428-61.47921621930.88291.560.3312806600.66700782CS
52-0.9599-73.83846153851.32.570.3310980460.92463529CS
156-3.4599-91.053.85.850.335300661.45998306CS
260-2.5099-88.06666666672.857.720.334386182.36263057CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 2.46
(96.80%)
29.94M
GREEGreenidge Generation Holdings Inc
$ 3.83
(55.06%)
6.93M
IBGInnovation Beverage Group Limited
$ 1.58
(46.45%)
1.54M
RBBRBB Bancorp
$ 35.01
(41.00%)
314
GANXGain Therapeutics Inc
$ 2.40
(37.54%)
337
TFFPTFF Pharmaceuticals Inc
$ 0.47
(-70.63%)
304.58k
PGCPeapack Gladstone Financial Corporation
$ 25.01
(-31.39%)
25
HSTMHealthStream Inc
$ 22.00
(-31.31%)
100
HTBIHomeTrust Bancshares Inc
$ 26.20
(-29.85%)
104
QUBTQuantum Computing Inc
$ 3.10
(-29.55%)
4.6M
BENFBeneficient
$ 2.45
(96.00%)
29.95M
ELABElevai Labs Inc
$ 0.0221
(-15.65%)
27.21M
GREEGreenidge Generation Holdings Inc
$ 3.83
(55.06%)
6.93M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 17.68
(0.40%)
6.45M
QUBTQuantum Computing Inc
$ 3.10
(-29.55%)
4.6M

EYEN Discussion

View Posts
RC_702 RC_702 1 month ago
And then again, maybe not. You still up 200% or did you sell during that balloon ride
👍️0
saigai saigai 2 months ago
still holding.. see you at trips
👍️0
saigai saigai 2 months ago
just going to hold i dont care anymore im tired of wishing on a star..im better off spending my days with the prayer beads than this nonsense
👍️0
saigai saigai 2 months ago
eyen 3200 at .59 lets gooo
👍️0
rosemountbomber rosemountbomber 3 months ago
Have to agree with you. I was surprised at the size of this offering. Rather not go through this again so will lighten up or liquidate completely on the next strong upward move.
👍️0
ProLiberty ProLiberty 3 months ago
It cost the company a 40% decline and dilution at $0.40 in exchange for 2.5 months of added runway. Not long ago they raised another $5m from 2 investors at $0.62 + warrants (also dilutive). They hope Oct data will allow accelerated approval of Micropine but even if good and accelerated still 12 months from approval. They will still burn and need to raise multiple times between now and 12 months from now. Perhaps they will be able to do it at a higher stock price if the Oct data is good but unclear. To buy today you need to be very confident that Oct data will be excellent.
👍️0
Monksdream Monksdream 3 months ago
EYEN new 52 low
👍️0
govprs govprs 3 months ago
I added. Great buy the dip opportunity
👍️0
rosemountbomber rosemountbomber 3 months ago
Well the good thing arrived this morning. 13 million share dilution:

https://finance.yahoo.com/news/eyenovia-announces-pricing-5-14-132900005.html
👍️0
Southern Gal Southern Gal 4 months ago
Another good day. I'm up 93.15% in 2 months time.

Typically, when an insider loads up, good thing are coming.
👍️0
rosemountbomber rosemountbomber 4 months ago
Thanks. Info 20 days late
👍️ 1
glenn1919 glenn1919 4 months ago
EYEN............................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
Southern Gal Southern Gal 4 months ago
INSIDER BUYS $660,000 WORTH OF EYEN
Name: GRANT STUART M
Symbol Date Shares Proceeds Transaction Details
EYEN 2024-07-02 1.515M $1,000,000.00 Purchase at $0.66 per share.

https://benchwalk.com/bench-walk-advisors-llc-litigation-financing-experts-team/stuart-grant-co-founder-managing-director
👍️0
Monksdream Monksdream 4 months ago
EYEN under $2
👍️0
Southern Gal Southern Gal 4 months ago
Wow!! Another BIG up day

$1.18

+$0.11
+10.28%
👍️0
Southern Gal Southern Gal 4 months ago
Well- I got my $1. Looking for more
👍️0
Southern Gal Southern Gal 6 months ago
Picked up more today.
Time will tell...
👍️0
Southern Gal Southern Gal 6 months ago
I started buying today. Looking for $1
👍️0
Dennis14 Dennis14 7 months ago
I bought in today. Now I’ll sit and wait.
👍️0
Monksdream Monksdream 7 months ago
EYEN new 52 lo
👍️0
Monksdream Monksdream 7 months ago
EYEN new 52 lo
👍️0
Monksdream Monksdream 8 months ago
EYEN under $2
👍️0
Monksdream Monksdream 8 months ago
EYEN under $2
👍️0
glenn1919 glenn1919 8 months ago
EYEN..........................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 9 months ago
EYEN.......................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 9 months ago
EYEN under $2
👍️0
Monksdream Monksdream 1 year ago
EYEN new 52 week low
👍️0
Monksdream Monksdream 1 year ago
EYEN new 52 week low
👍️0
Monksdream Monksdream 1 year ago
EYEN under $2
👍️0
honest dave honest dave 3 years ago
EYEN --
--Northland Adjusts Eyenovia's Price Target to $9 From $12, Maintains Outperform Rating
BY MT Newswires
— 9:31 AM ET 10/26/2021
👍️0
jdlamont jdlamont 4 years ago
EYEN now trading options!!!!
👍️0
jdlamont jdlamont 4 years ago
EYEN now trading options!!!!
👍️0
beambe beambe 4 years ago
Good NEWS
👍️0
beambe beambe 4 years ago
good Volume
👍️0
beambe beambe 4 years ago
https://eyenovia.com/about-2019/

👍️0
ClayTrader ClayTrader 4 years ago
* * $EYEN Video Chart 08-11-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
beambe beambe 4 years ago
good Volume
👍️0
breezy1 breezy1 4 years ago
OCGN - .62 orphan FDA approvals
👍️0
crudeoil24 crudeoil24 4 years ago
Eyenovia and Arctic Vision Announce Exclusive Collaboration and License Agreement to Develop and Commercialize MicroPine and MicroLine in Greater China and South Korea
8:05 am ET August 11, 2020 (Globe Newswire) Print
Eyenovia Eligible to Receive up to a Total of $45.75 million in Upfront Payments and Development and Commercialization Milestones and Development Costs

Arctic Vision to Lead Expansion of Novel Approach to Treating Myopia and Presbyopia in Greater China and South Korea

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP(TM)) therapeutics and Arctic Vision, a clinical stage biotech company focused on developing and commercializing innovative ophthalmology therapies in China and Asia, today announced that they have entered into an exclusive license agreement for Arctic Vision to develop and commercialize MicroPine for the treatment of progressive myopia and MicroLine for the treatment of presbyopia in Greater China (mainland China, Hong Kong, Macau and Taiwan) and South Korea.

Under the terms of the agreement, Eyenovia may receive up to a total of $45.75 million in upfront payments as well as additional payments, based on various development and regulatory milestones, including the initiation of clinical research and approvals in Greater China and South Korea, and development costs. In addition, Arctic Vision will purchase its supply of MicroPine and MicroLine from Eyenovia or, for such products not supplied by Eyenovia, pay Eyenovia a mid-single digit percentage royalty on net sales of such products, subject to certain adjustments. Eyenovia will pay a mid-double digit percentage of such payments, royalties, or net proceeds of such supply to its Asian licensee pursuant to the arrangement
👍️0
BioSpecialist BioSpecialist 4 years ago
next $10 stock soon
👍️0
BioSpecialist BioSpecialist 4 years ago
STRONG BUY
👍️0
BioSpecialist BioSpecialist 4 years ago
EYEN = MC $60 Million /NDA submission for BIG drug in Q3 / 2 more Drugs in Phase 3 including a potential Blockbuster /Undiscovered low float gem = A Potential 10+ Bagger Gem ..GLTA



👍️0
jdlamont jdlamont 5 years ago
anyone who sees the video of the kid using the machine will buy the stock.
So easy and simple to use-REVOLUTIONARY. Very impressive.
👍️0
ADVFN_bioking ADVFN_bioking 5 years ago
RALLLYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY
👍️0
ADVFN_bioking ADVFN_bioking 5 years ago
looks like next breakout about to start
👍️0
ADVFN_bioking ADVFN_bioking 5 years ago
Load up before she takes off again
👍️0
ADVFN_bioking ADVFN_bioking 5 years ago
STRONG BUY this pure undiscovered Goldmine
👍️0
JGCola JGCola 5 years ago
Down a lot today. I'd say related to ALDX (another "eyes" biotech) which is down about 32% following Top-Line results. It's a mistake to associate the faith of those 2 IMO. This is creating a great opportunity. Will go back over 4$ very soon and may never "look" back. This wild horse will suddenly run free at some point. Great MGT. Founder keeps on buying. Great innovation. First-in-class comes to mind.
👍️0
jdlamont jdlamont 5 years ago
4 years from now 300 dollar stock when myopia drug approved
👍️0
ADVFN_bioking ADVFN_bioking 5 years ago
UUUUUUUUUUUUUUUUUUUP again and still terrible undervalued
👍️0

Your Recent History

Delayed Upgrade Clock